BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37576516)

  • 1. Development and Validation of a Nomogram to Predict Significant Liver Inflammation in Patients with Chronic Hepatitis B.
    Jiang S; Wang J; Zhang Z; Zhan J; Xue R; Qiu Y; Zhu L; Zhang S; Pan Y; Yan X; Chen Y; Li J; Liu X; Zhu C; Huang R; Wu C
    Infect Drug Resist; 2023; 16():5065-5075. PubMed ID: 37576516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive diagnosis of significant liver inflammation in patients with chronic hepatitis B in the indeterminate phase.
    Zhan J; Wang J; Zhang Z; Xue R; Jiang S; Liu J; Liu Y; Zhu L; Xia J; Yan X; Ding W; Zhu C; Qiu Y; Li J; Huang R; Wu C
    Virulence; 2023 Dec; 14(1):2268497. PubMed ID: 37938933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Develop and validate a novel online AIHI-nomogram to predict severe liver inflammation in patients with autoimmune hepatitis.
    Zhang Z; Wang J; Wang H; Li Y; Zhu L; Chen Y; Liu J; Liu Y; Chen Y; Yin S; Tong X; Yan X; Yang Y; Zhu C; Li J; Qiu Y; Huang R; Wu C
    Ann Hepatol; 2023; 28(6):101134. PubMed ID: 37442347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nomogram based on HBeAg, AST, and age to predict non-minimal liver inflammation in CHB patients with ALT <80 U/L.
    Zhang L; Bi X; Chen X; Zhang L; Xiong Q; Cao W; Lin Y; Yang L; Jiang T; Deng W; Wang S; Wu S; Liu R; Gao Y; Shen G; Chang M; Hao H; Xu M; Hu L; Lu Y; Li M; Xie Y
    Front Immunol; 2022; 13():1119124. PubMed ID: 36741383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel index using routine clinical parameters for predicting significant liver inflammation in chronic hepatitis B.
    Wang J; Xia J; Zhang R; Yan X; Yang Y; Zhao X; Chang H; Wang G; Chen G; Liu Y; Chen Y; Jia B; Zhang Z; Ding W; Huang R; Wu C
    J Viral Hepat; 2018 Oct; 25(10):1151-1160. PubMed ID: 29741221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Prediction Model for Significant Liver Fibrosis in Patients with Chronic Hepatitis B.
    Chen Y; Gong J; Zhou W; Jie Y; Li Z; Chong Y; Hu B
    Biomed Res Int; 2020; 2020():6839137. PubMed ID: 32695818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An easy-to-use AIHF-nomogram to predict advanced liver fibrosis in patients with autoimmune hepatitis.
    Zhang Z; Wang J; Wang H; Qiu Y; Zhu L; Liu J; Chen Y; Li Y; Liu Y; Chen Y; Yin S; Tong X; Yan X; Xiong Y; Yang Y; Zhang Q; Li J; Zhu C; Wu C; Huang R
    Front Immunol; 2023; 14():1130362. PubMed ID: 37266419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Non-invasive Model for Predicting Liver Inflammation in Chronic Hepatitis B Patients With Normal Serum Alanine Aminotransferase Levels.
    Li X; Xing Y; Zhou D; Xiao H; Zhou Z; Han Z; Sun X; Li S; Zhang L; Li Z; Zhang P; Zhang J; Zhang N; Cao X; Zao X; Du H; Tong G; Chi X; Gao Y; Ye Y
    Front Med (Lausanne); 2021; 8():688091. PubMed ID: 34150818
    [No Abstract]   [Full Text] [Related]  

  • 9. The gamma-glutamyl transpeptidase to platelet ratio predicts liver inflammation in chronic hepatitis B with normal or mildly elevated alanine transaminase.
    Wang J; Xia J; Yan X; Yang Y; Wei J; Xiong Y; Wu W; Liu Y; Chen Y; Jia B; Chen Z; Zhang Z; Ding W; Huang R; Wu C
    Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):913-922. PubMed ID: 32147439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of pseudo-immune tolerance for chronic hepatitis B patients: Development and validation of a non-invasive prediction model.
    Li S; Li Z; Du H; Zao X; Gan D; Yang X; Li X; Xing Y; Ye Y
    Front Public Health; 2023; 11():1137738. PubMed ID: 37089512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Non-invasive Model to Predict Liver Inflammation in Chronic Hepatitis B With Alanine Aminotransferase ≤ 2 Upper Limit of Normal.
    Chen S; Huang H
    Front Med (Lausanne); 2021; 8():661725. PubMed ID: 34150800
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic Value of Inflammatory Indicators in Chronic Hepatitis B Patients With Significant Liver Fibrosis: A Multicenter Study in China.
    Zhang X; Jie Y; Wan Z; Lin S; Li Y; Lin M; Wu S; Wu X; Shi M; Xiao H; Cao M; Gong J; Chi X
    Front Pharmacol; 2021; 12():653751. PubMed ID: 34858162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nomogram for discrimination of non-alcoholic fatty liver disease in patients with chronic hepatitis B.
    Chen Y; Cao D; Li C; Zhang P; Wang X; Li N; Han Q; Liu Z
    Eur J Gastroenterol Hepatol; 2021 Jan; 33(1):69-75. PubMed ID: 32118853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development a novel nomogram model for predicting significant hepatic histological changes in chronic hepatitis B virus carriers.
    Kang NL; Gao YH; Lin MX; Wu LY; Ye XY; Lin HM; Ruan QF; Lin S; Liu HH; Huang LL; Jiang JJ; Liu YR; Zheng Q; Mao RC; Zeng DW
    J Med Virol; 2023 Jul; 95(7):e28943. PubMed ID: 37436779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase.
    Zeng DW; Dong J; Jiang JJ; Zhu YY; Liu YR
    World J Gastroenterol; 2016 Nov; 22(43):9586-9594. PubMed ID: 27920479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum ceruloplasmin levels correlate negatively with liver fibrosis in males with chronic hepatitis B: a new noninvasive model for predicting liver fibrosis in HBV-related liver disease.
    Zeng DW; Liu YR; Zhang JM; Zhu YY; Lin S; You J; Li YB; Chen J; Zheng Q; Jiang JJ; Dong J
    PLoS One; 2013; 8(10):e77942. PubMed ID: 24282481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-glutamyl Transpeptidase to Platelet Ratio Predicts Liver Injury in Hepatitis B e Antigen-negative Chronic Hepatitis B Patients With Normal Alanine Aminotransferase.
    Zhao XA; Wang J; Wei J; Liu J; Chen G; Wang L; Wang G; Xia J; Wu W; Yin S; Tong X; Yan X; Ding W; Xiang X; Huang R; Wu C
    J Clin Transl Hepatol; 2022 Apr; 10(2):247-253. PubMed ID: 35528978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applicability of liver stiffness measurement based nomograms to the assessments of hepatitis B related significant fibrosis and cirrhosis.
    Ji SS; Jiang HD; Jiang JC; Li J; Lin ST; Chen B; Xu SH
    Clin Chim Acta; 2019 Feb; 489():75-82. PubMed ID: 30471249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical noninvasive markers for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase less than two times upper limit of normal.
    Wu Z; Dong X; Wang G; Zhao H;
    J Viral Hepat; 2019 Feb; 26(2):287-296. PubMed ID: 30380162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A noninvasive model to predict liver histology for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase < 2 upper limit of normal.
    Chen S; Huang H; Huang W
    BMC Gastroenterol; 2021 Jan; 21(1):4. PubMed ID: 33407146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.